LGVN · Longeveron Inc. · Executive Compensation
$2.69
-0.03 (-1.10%)
At close · Sep 30
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have prepared a cash flow forecast which indicates that we do not have sufficient cash to meet our minimum expenditure commitments for one year from the date these financial statements are available to be issued and therefore we need to raise additional funds to continue as a going concern. As a result, there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$8.96M
Shares
3.19M
Volume · Sep 30
54.97K
Avg daily vol (24 sessions)
165.5K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Wa’el Hashad | Former Chief Executive Officer | $1,281,252 |
| Paul Lehr | General Counsel and Corporate Secretary | $1,049,516 |
| Lisa Locklear | Chief Financial Officer and Treasurer | $862,087 |
| J. Nathaniel Powell | Former Interim Chief Executive Officer | $475,824 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Wa’el Hashad | Chief Executive Officer | $1,848,739 |
| Paul Lehr | General Counsel and Corporate Secretary | $1,226,696 |
| Lisa Locklear | Chief Financial Officer, Treasurer | $1,123,251 |
| J. Nathaniel Powell | Former Interim Chief Executive Officer | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Wa’el Hashad | Chief Executive Officer | $1,576,559 |
| Paul Lehr | General Counsel and Corporate Secretary | $554,055 |
| James Clavijo | — | $525,915 |
| Lisa Locklear | Chief Financial Officer, Treasurer | $380,779 |
| K. Chris Min | former interim CEO | $284,696 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| K. Chris Min | former interim CEO | $2,925,288 |
| Paul Lehr | General Counsel and Corporate Secretary | $983,158 |
| Former CFO | Treasurer | $774,558 |
| Geoff Green | — | $485,323 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Former CEO | — | $2,529,804 |
| Geoff Green | CEO | $2,529,804 |
| Paul Lehr | General Counsel and Corporate Secretary | $2,056,056 |
| James Clavijo | CFO, Treasurer | $1,589,929 |
| Joshua Hare | M.D., CSO, | $1,324,923 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Joshua Hare | M.D., CSO, | $270,000 |
| Geoff Green | CEO | $234,334 |
| Paul Lehr | International General Counsel and Corporate Secretary | $182,650 |
| James Clavijo | CFO, Treasurer | $171,806 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Nirav S. Jhaveri | Chief Financial Officer, principal financial officer and principal accounting officer | Appointed | 2026-08-19 |
| Arjun "JJ" Desai | Class III director | Appointed | 2026-07-06 |
| Marie Washburn | Senior Vice President and Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer | Appointed | 2026-07-06 |
| Lisa Locklear | Chief Financial Officer | Resigned | 2026-06-05 |
| Dr. Roger Hajjar | member of the Audit Committee | Appointed | 2026-03-09 |
| Mr. Richard Kender | member of the Board of Directors and Audit Committee, chairman of the Audit Committee and the audit committee financial expert | Resigned | 2026-03-09 |
| Stephen H. Willard | Chief Executive Officer | Appointed | 2026-02-13 |
| Than Powell | Interim Chief Executive Officer | Resigned | 2026-02-13 |
| Neha Motwani | Board of Directors | Resigned | 2025-11-12 |
| Khoso Baluch | Board of Directors | Resigned | 2025-11-12 |
| George Paletta | Class I director | Appointed | 2025-10-01 |
| Than Powell | interim Chief Executive Officer | Appointed | 2025-09-03 |
| Neil Hare | Board of Directors | Resigned | 2025-01-30 |
| Cathy Ross | Board of Directors | Resigned | 2024-05-10 |
| Richard Kender | Class II director | Appointed | 2024-05-10 |
| Jeffrey Pfeffer | Board of Directors | Resigned | 2024-05-10 |
| Lisa Locklear | Executive Vice President and Chief Financial Officer | Appointed | 2023-07-20 |
| Dr. Nataliya Agafonova M.D. | Chief Medical Officer | Appointed | 2023-07-05 |
| James Clavijo | interim Chief Financial Officer | Appointed | 2023-06-05 |
| James Clavijo | Chief Financial Officer | Resigned | 2023-04-10 |
| Wa'el Hashad | Chief Executive Officer | Appointed | 2023-02-28 |